Jane Street
KRTX

Jane Street’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jane Street’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,456
Closed -$1.09M – 10354
2023
Q4 		$1.09M Sell
3,456
-6,808
-66% -$1.32M ﹤0.01% 5401
2023
Q3 		$1.74M Sell
10,264
-49,673
-83% -$9.34M ﹤0.01% 4284
2023
Q2 		$13M Buy
+59,937
New +$12.8M ﹤0.01% 1636
2023
Q1 		– Sell
-34,581
Closed -$6.61M – 10222
2022
Q4 		$6.8M Sell
34,581
-13,243
-28% -$2.84M ﹤0.01% 2078
2022
Q3 		$10.8M Buy
47,824
+43,659
+1,048% +$8.84M ﹤0.01% 1611
2022
Q2 		$527K Buy
4,165
+30
+0.7% +$3.45K ﹤0.01% 6639
2022
Q1 		$524K Sell
4,135
-5,223
-56% -$588K ﹤0.01% 7386
2021
Q4 		$1.23M Buy
+9,358
New +$1.21M ﹤0.01% 5489
2021
Q1 		– Sell
-6,948
Closed -$787K – 9719
2020
Q4 		$706K Sell
6,948
-3,815
-35% -$353K ﹤0.01% 5209
2020
Q3 		$832K Sell
10,763
-30,604
-74% -$2.61M ﹤0.01% 4400
2020
Q2 		$4.61M Buy
+41,367
New +$3.6M ﹤0.01% 1949
2020
Q1 		– Sell
-10,673
Closed -$804K – 6156
2019
Q4 		$804K Buy
+10,673
New +$467K ﹤0.01% 3077

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jane Street's KRTX Position: Q1 2024 in Review

Jane Street sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,456 shares — an estimated $1.09M sold.

Jane Street first reported a position in KRTX in Q4 2019 and held it in 12 quarters. The position peaked at $13M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Jane Street reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 3,456 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.09M.
  • Jane Street first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Jane Street's Karuna Therapeutics, Inc. Common Stock position peaked at $13M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.